metronidazole has been researched along with pulmicort in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 16 (55.17) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Rutgeerts, P; Vermeire, S | 1 |
| Breslin, NP; Sutherland, LR | 1 |
| Bai, JC; Boerr, L; Cabanne, A; Camartino, G; Doldán, I; Gil, A; Gonzalez, O; Graziano, A; Huernos, S; Kogan, Z; Lumi, M; Negreira, S; Peredo, H; Sambuelli, A; Sugai, E | 1 |
| Bitton, A; Cohen, A; Croitoru, K; Drouin, E; Feagan, BG; Greenberg, GR; Leddin, DJ; Mikolainis, S; Seidman, E; Steinhart, AH; Vandervoort, M; Wong, CJ | 1 |
| Beglinger, Ch | 1 |
| Calabrese, E; Cammà, C; Casà, A; Cottone, M; Orlando, A; Viscido, A | 1 |
| Croitoru, K; Feagan, BG; Greenberg, GR; Landers, CJ; Mow, WS; Seidman, E; Steinhart, AH; Targan, SR | 1 |
| Herrlinger, K; Stange, EF | 1 |
| Cantoni, A; Coruzzi, G; Giovannini, E; Grandi, D; Lazzaretti, M; Menozzi, A; Poli, E; Pozzoli, C | 1 |
| Detsky, A; Kennedy, ED; Llewellyn-Thomas, HA; McLeod, RS; Steinhart, AH; To, T | 1 |
| Dilger, K; Fux, R; Gleiter, CH; Mörike, K; Röck, D | 1 |
| Hooker, M | 1 |
| Dunzendorfer, T; Johnson, R; Wilkins, S | 1 |
| Madisch, A | 1 |
| Bell, AJ; Ciclitira, PJ; Clark, SK; McLaughlin, SD; Nicholls, RJ; Tekkis, PP | 1 |
| Holubar, SD; Pardi, DS; Sandborn, WJ; Singh, S; Stroud, AM | 1 |
| Holubar, SD; Nguyen, N; Pardi, DS; Singh, S; Zhang, B | 2 |
| Benlice, C; Shen, B; Steele, SR | 1 |
| Barreiro-de Acosta, M; Beltrán, B; Chaparro, M; Espín, E; Ferrer Bradley, I; Gisbert, JP; Guarner, F; Gutiérrez, A; Marín-Jimenez, I; Nos, P; Rodríguez-Lago, I | 1 |
| Alphonsus, L; Beaton, M; Bessissow, T; De Silva, TA; Hanzel, J; Jairath, V; Kayal, M; Ma, C; MacDonald, JK; Sedano, R; Singh, S | 1 |
12 review(s) available for metronidazole and pulmicort
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].
Topics: Anti-Inflammatory Agents; Budesonide; Colon; Crohn Disease; Follow-Up Studies; Humans; Ileum; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 1998 |
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Digestive System Surgical Procedures; Humans; Mesalamine; Metronidazole; Postoperative Period; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention | 1998 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Ornidazole; Probiotics; Risk Factors; Secondary Prevention; Smoking | 2003 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Clostridium difficile.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Beclomethasone; Biopsy; Budesonide; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infection Control; Male; Metronidazole; Middle Aged; Oncology Nursing; Primary Myelofibrosis; Risk Factors; Tacrolimus; Vancomycin | 2007 |
[Diagnostics and therapy of chronic diarrhea in elderly people].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Budesonide; Cholestyramine Resin; Chronic Disease; Clostridioides difficile; Colitis, Microscopic; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Glucocorticoids; Humans; Intestinal Diseases; Irritable Bowel Syndrome; Medical History Taking; Metronidazole; Randomized Controlled Trials as Topic; Time Factors | 2008 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Adult; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction; Rifamycins; Rifaximin; Suppositories | 2015 |
Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis.
Topics: Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Humans; Male; Metronidazole; Pouchitis; Proctocolectomy, Restorative; Prognosis; Rifaximin | 2019 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Probiotics; Randomized Controlled Trials as Topic; Remission Induction | 2019 |
Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis.
Topics: Adult; Budesonide; Ciprofloxacin; Humans; Metronidazole; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction | 2023 |
4 trial(s) available for metronidazole and pulmicort
| Article | Year |
|---|---|
Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Budesonide; Double-Blind Method; Enema; Female; Humans; Male; Metronidazole; Middle Aged; Pouchitis; Treatment Outcome | 2002 |
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Budesonide; Ciprofloxacin; Colon; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ileum; Male; Metronidazole; Remission Induction; Treatment Outcome | 2002 |
High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.
Topics: Anti-Infective Agents; Antibodies, Antineutrophil Cytoplasmic; Antigens, Bacterial; Budesonide; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Metronidazole; Pilot Projects; Porins; Pseudomonas fluorescens; Remission Induction; Superantigens | 2004 |
Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study.
Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Bacterial Agents; Antiprotozoal Agents; Area Under Curve; Budesonide; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Hydrocortisone; Male; Metronidazole; Tandem Mass Spectrometry | 2007 |
13 other study(ies) available for metronidazole and pulmicort
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Disease Models, Animal; Male; Metronidazole; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tylosin | 2005 |
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
Topics: Adult; Aged; Azathioprine; Budesonide; Canada; Crohn Disease; Cross-Sectional Studies; Decision Support Techniques; Fees, Pharmaceutical; Female; Fish Oils; Focus Groups; Gastrointestinal Agents; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Patient Satisfaction; Postoperative Care; Regression Analysis; Reproducibility of Results; Secondary Prevention | 2008 |
Mucosal tear in collagenous colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Biopsy; Bismuth; Budesonide; Ciprofloxacin; Colitis, Collagenous; Colonoscopy; Enema; Female; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 2009 |
Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Female; Humans; Ileitis; Incidence; Male; Mesalamine; Metronidazole; Middle Aged; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Retrospective Studies | 2009 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Probiotics; Randomized Controlled Trials as Topic; Remission Induction | 2019 |
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
Topics: Acute Disease; Advisory Committees; Algorithms; Anti-Bacterial Agents; Biological Products; Budesonide; Chronic Disease; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Enema; Humans; Ileostomy; Immunosuppressive Agents; Metronidazole; Postoperative Complications; Pouchitis; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention; Spain | 2020 |